Related Experiment Video
Updated: Jun 17, 2026

Minimally Invasive Transverse Aortic Constriction in Mice
Published on: March 14, 2017
Mavacamten as an Effective Treatment for HCM With Latent Exercise-Induced Obstruction: A Case Report
Nikitha Murthy1, Brian Diep1, Jonathan Evans1
1Division of Cardiology, Loma Linda University Health, Loma Linda, California, USA, lluh.org.
Background:
Hypertrophic cardiomyopathy (HCM) is a myocardial disorder characterized by hypertrophy of the left ventricle that can lead to significant symptoms, particularly with exercise. For patients with HCM who demonstrate obstructive physiology, the first-in-class targeted cardiac specific myosin inhibitor, mavacamten, has been found to reduce the degree of obstruction as well as symptoms.
Case Summary:
We present a patient with symptomatic HCM who had no left ventricular outflow tract obstruction (LVOTO) at rest but demonstrated obstruction on treadmill stress echocardiography. She had symptomatic improvement after treatment with mavacamten.
Discussion:
Patients with symptomatic HCM who do not demonstrate elevated resting gradients may benefit from evaluation of exercise-induced gradients to diagnose obstructive HCM and guide initiation of targeted therapy with mavacamten.
Take Home Message:
Mavacamten may be safe and effective in patients who demonstrate LVOTO only upon provocation with exercise.
More Related Videos
07:02Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy
Published on: September 9, 2020
07:38Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Related Concept Videos
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care